Luciano Levato

3.0k total citations
39 papers, 659 citations indexed

About

Luciano Levato is a scholar working on Genetics, Pathology and Forensic Medicine and Immunology. According to data from OpenAlex, Luciano Levato has authored 39 papers receiving a total of 659 indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Genetics, 21 papers in Pathology and Forensic Medicine and 12 papers in Immunology. Recurrent topics in Luciano Levato's work include Chronic Lymphocytic Leukemia Research (35 papers), Lymphoma Diagnosis and Treatment (21 papers) and Immunodeficiency and Autoimmune Disorders (11 papers). Luciano Levato is often cited by papers focused on Chronic Lymphocytic Leukemia Research (35 papers), Lymphoma Diagnosis and Treatment (21 papers) and Immunodeficiency and Autoimmune Disorders (11 papers). Luciano Levato collaborates with scholars based in Italy, United States and United Kingdom. Luciano Levato's co-authors include Stefano Molica, Domenico Levato, Diana Giannarelli, Pellegrino Musto, Nicola Cascavilla, S. Molica, Delphine Réa, Phillipp D. Le Coutre, Ivo Buschmann and Franck E. Nicolini and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Leukemia.

In The Last Decade

Luciano Levato

35 papers receiving 646 citations

Peers

Countries citing papers authored by Luciano Levato

Since Specialization

Citations

This map shows the geographic impact of Luciano Levato's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luciano Levato with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luciano Levato more than expected).

Fields of papers citing papers by Luciano Levato

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Luciano Levato. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luciano Levato. The network helps show where Luciano Levato may publish in the future.

Co-authorship network of co-authors of Luciano Levato

This figure shows the co-authorship network connecting the top 25 collaborators of Luciano Levato. A scholar is included among the top collaborators of Luciano Levato based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Luciano Levato. Luciano Levato is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Real-Life Data of Bosutinib Treatment for Chronic Myeloid Leukemia: The Multi-Center Experience of the Gruppo Di Miglioramento Sicilia-Calabria 2023 ·Blood ·Marco Santoro, Sabina Russo, Iolanda Donatella Vincelli, (unknown), Stefana Impera, Vincenzo Leone, Luciano Levato, Francesco Mendicino, Alessandra Malato, (unknown), (unknown), Ferdinando Porretto, Bruno Martino, Sergio Siragusa, (unknown)	0
2	Efficacy of the BNT162b2 mRNA COVID-19 Vaccine in Patients with Chronic Lymphocytic Leukemia: A Serologic and Cellular Study 2021 ·Chemotherapy ·Stefano Molica, Diana Giannarelli, (unknown), (unknown), (unknown), (unknown), Valentina Gianfelici, (unknown), (unknown), (unknown), (unknown), Luciano Levato	15
3	The BALL prognostic score identifies relapsed/refractory CLL patients who benefit the most from single-agent ibrutinib therapy 2020 ·Leukemia Research ·Stefano Molica, Tycho Baumann, (unknown), Luciano Levato, Julio Delgado, Emili Montserrat	5
4	Sustained Complete Remission with Incomplete Hematologic Recovery (CRi) in a Patient with Relapsed AML and Concurrent BCR-ABL1 and CBFB Rearrangement Treated with a Combination of Venetoclax and 5-Azacytidine 2020 ·Chemotherapy ·Luciano Levato, Valentina Gianfelici, (unknown), Antonio Russo, Emilia Giugliano, (unknown), Stefano Molica	2
5	The Evolution of Targeted Therapies in Chronic Lymphocytic Leukaemia 2020 ·Current Hematologic Malignancy Reports ·Valentina Gianfelici, Luciano Levato, Stefano Molica	3
6	Dabigatran in ibrutinib-treated patients with atrial fibrillation and chronic lymphocytic leukemia: experience of three cases 2020 ·Blood Coagulation & Fibrinolysis ·Rita Santoro, (unknown), Luciano Levato, (unknown), (unknown)	0
7	Chronic lymphocytic leukemia international prognostic index (CLL-IPI) in patients receiving chemoimmuno or targeted therapy: a systematic review and meta-analysis 2018 ·Annals of Hematology ·Stefano Molica, Diana Giannarelli, (unknown), Luciano Levato, Tait D. Shanafelt	20
8	Rituximab in the management of acute lymphoblastic leukemia 2018 ·Expert Opinion on Biological Therapy ·Luciano Levato, Stefano Molica	12
9	A simple score based on geriatric assessment predicts survival in elderly newly diagnosed chronic lymphocytic leukemia patients 2018 ·Leukemia & lymphoma ·Stefano Molica, Diana Giannarelli, Luciano Levato, (unknown), Domenico Levato, (unknown), Eugenio Piro	12
10	The magnitude of improvement in progression-free survival with targeted therapy in relapsed/refractory chronic lymphocytic leukemia based on prognostic risk category: a systematic review and meta-analysis 2018 ·Leukemia & lymphoma ·Stefano Molica, Diana Giannarelli, (unknown), Luciano Levato, Tait D. Shanafelt	7
11	Chronic lymphocytic leukemia international prognostic index: a systematic review and meta-analysis 2017 ·Blood ·Stefano Molica, Diana Giannarelli, (unknown), Luciano Levato, Neil E. Kay, Tait D. Shanafelt	12
12	Unavailability of thymidine kinase does not preclude the use of German comprehensive prognostic index: results of an external validation analysis in early chronic lymphocytic leukemia and comparison with MD Anderson Cancer Center model 2015 ·European Journal Of Haematology ·Stefano Molica, Diana Giannarelli, (unknown), Luciano Levato, Antonio Russo, (unknown), Massimo Gentile, Fortunato Morabito	12
13	Changes in the incidence, pattern of presentation and clinical outcome of early chronic lymphocytic leukemia patients using the 2008 International Workshop on CLL guidelines 2014 ·Expert Review of Hematology ·Stefano Molica, Diana Giannarelli, (unknown), Luciano Levato, Massimo Gentile, (unknown), Fortunato Morabito	7
14	A prognostic algorithm including a modified version of MD Anderson Cancer Center (MDACC) score predicts time to first treatment of patients with clinical monoclonal lymphocytosis (cMBL)/Rai stage 0 chronic lymphocytic leukemia (CLL) 2014 ·International Journal of Hematology ·Stefano Molica, Diana Giannarelli, Luciano Levato, (unknown), Massimo Gentile, (unknown), Fortunato Morabito	4
15	Peripheral artery occlusive disease in chronic phase chronic myeloid leukemia patients treated with nilotinib or imatinib 2013 ·Leukemia ·(unknown), Delphine Réa, Michaela Schwarz, (unknown), Franck E. Nicolini, Gianantonio Rosti, Luciano Levato, Francis J. Giles, Hervé Dombret, Tristan Mirault, Hélène Labussière, Ruhdja Lindhorst, Wilhelm Haverkamp, Ivo Buschmann, Bernd Dörken, Phillipp D. Le Coutre	171
16	Vitamin D insufficiency predicts time to first treatment (TFT) in early chronic lymphocytic leukemia (CLL) 2011 ·Leukemia Research ·Stefano Molica, Giovanna Digiesi, Anna Antenucci, Luciano Levato, (unknown), Matteo Molica, Massimo Gentile, Diana Giannarelli, Isabella Sperduti, Fortunato Morabito, Laura Conti	21
17	The long-term durability of cytogenetic responses in patients with accelerated phase chronic myeloid leukemia treated with imatinib 600 mg: the GIMEMA CML Working Party experience after a 7-year follow-up 2009 ·Haematologica ·Francesca Palandri, Fausto Castagnetti, G. Alimena, Nicoletta Testoni, (unknown), Simona Luatti, Giovanna Rege‐Cambrin, Fabio Stagno, Giorgina Specchia, B. Martino, Luciano Levato, Serena Merante, Anna Marina Liberati, Fabrizio Pane, Giuseppe Saglio, Daniele Alberti, Giovanni Martinelli, Michele Baccarani, Giovanni Rosti	57
18	Clinico‐prognostic implications of simultaneous increased serum levels of soluble CD23 and β₂‐microglobulin in B‐cell chronic lymphocytic leukemia 1999 ·European Journal Of Haematology ·Stefano Molica, Domenico Levato, Nicola Cascavilla, Luciano Levato, Pellegrino Musto	74
19	Expression on leukemic cells and serum circulating levels of intercellular adhesion molecule-1 (ICAM-1) in B-cell chronic lymphocytic leukemia: Implications for prognosis 1995 ·Leukemia Research ·Stefano Molica, A Dattilo, (unknown), Domenico Levato, Luciano Levato	18
20	Infections in chronic lymphocytic leukemia. Analysis of incidence as a function of length of follow-up. 1993 ·PubMed ·S. Molica, Domenico Levato, Luciano Levato	37

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact